Regis P Kowalski (Regis Kowalski)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Antibiotics (Basel, Switzerland)

Pathogens (Basel, Switzerland)

Clinical ophthalmology (Auckland, N.Z.)

Microorganisms

University of Pittsburgh

University of Pittsburgh (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh Sep 30 2010

United States

Executive Director - Professor :: Ophthalmology

Education History

University of Pittsburgh Sep 01 1972 - Apr 15 1982

United States

MSC :: Ophthalmology

Publications

David Mora-Boellstorff, Kanwal Matharu, Vishal Jhanji, Regis P Kowalski
Can Serum Drops Containing Doxycycline Provide a Supplemental Anti-Bacterial Effect in the Treatment of Bacterial Keratitis? Antibiotics (Basel, Switzerland) 12 (7) (2023)
Eric G Romanowski, Kathleen A Yates, Eric J Daniels, Brian M Strem, John E Romanowski, Regis P Kowalski
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model. Pathogens (Basel, Switzerland) 11 (12) (2022)
Eric G Romanowski, Kathleen A Yates, Eric J Daniels, Brian M Strem, John E Romanowski, Regis P Kowalski
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model. Pathogens (Basel, Switzerland) 11 (12) (2022)
Eric G Romanowski, Kathleen A Yates, Eric J Daniels, Brian M Strem, John E Romanowski, Regis P Kowalski
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model. Pathogens (Basel, Switzerland) 11 (12) (2022)
Regis P Kowalski, Shannon V Nayyar, Eric G Romanowski, Vishal Jhanji
Anti-Infective Treatment and Resistance Is Rarely Problematic with Eye Infections. Antibiotics (Basel, Switzerland) 11 (2) (2022)
Eric G Romanowski, Islam T M Hussein, Steven C Cardinale, Michelle M Butler, Lucas R Morin, Terry L Bowlin, Kathleen A Yates, Robert M Q Shanks, Regis P Kowalski
Filociclovir Is an Active Antiviral Agent against Ocular Adenovirus Isolates In Vitro and in the Ad5/NZW Rabbit Ocular Model. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Regis P Kowalski, Roheena Kamyar, Michelle Rhee, Alex Mammen, Deepinder Dhaliwal, Eric G Romanowski, Vishal Jhanji, Andrew W Eller
The Antibacterial Comparison of 5% and 2.5% Povidone Iodine to 0.01% Hypochlorous Acid Using Corneoscleral Tissue as a Solid-Phase Medium. Clinical ophthalmology (Auckland, N.Z.) 15 (2021)
John E Romanowski, Shannon V Nayyar, Eric G Romanowski, Vishal Jhanji, Robert M Q Shanks, Regis P Kowalski
Speciation and Antibiotic Susceptibilities of Coagulase Negative Staphylococci Isolated from Ocular Infections. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Nathaniel S Harshaw, Nicholas A Stella, Kara M Lehner, Eric G Romanowski, Regis P Kowalski, Robert M Q Shanks
Antibiotics Used in Empiric Treatment of Ocular Infections Trigger the Bacterial Rcs Stress Response System Independent of Antibiotic Susceptibility. Antibiotics (Basel, Switzerland) 10 (9) (2021)
Eric G Romanowski, Kathleen A Yates, John E Romanowski, Robert M Q Shanks, Regis P Kowalski
The in vitro Evaluation of the Activity of COVID-19 Antiviral Drugs Against Adenovirus. Clinical ophthalmology (Auckland, N.Z.) 15 (2021)
Samantha J LaCroce, Mollie N Wilson, John E Romanowski, Jeffrey D Newman, Vishal Jhanji, Robert M Q Shanks, Regis P Kowalski
Moraxella nonliquefaciens and M. osloensis Are Important Moraxella Species That Cause Ocular Infections. Microorganisms 7 (6) (2019)

Regis P Kowalski.css-eqlu8i{font-size:small;padding-left:4px;} (Regis Kowalski)

Publication Activity (10 Years)

Top Topics

Top Venues

Regis P Kowalski (Regis Kowalski)